Monitoring with mean kinetic temperature in GxP environments

Supplied by Vaisala Oyj on Tuesday, 14 February, 2017

Regulatory bodies in drug manufacturing and distribution have long been working together to create standards for temperature monitoring that will ensure the quality of drugs, devices and biotechnology. The mean kinetic temperature (MKT) value has been identified as a potential tool for evaluating the impact of temperature on product quality.

Download this paper to discover how to perform the calculation and some basic recommendations for its appropriate use.

DOWNLOAD

5 Pages PDF

Related White Papers

Monitoring secrets from North America’s largest healthcare services company

Learn about the cutting edge solutions McKesson implemented to optimise processes and deliver...

Minimise product contamination with elemental impurity testing

Learn about elemental impurity testing and how the recent innovation of microwave closed vessel...

9 steps to validate your life science storage

Good manufacturing practice regulators in Australia have sharpened their focus on life...

Content from other channels on our network

Community mistrust puts renewable energy rollout at risk

Aussie low-carbon concrete created using calcinated clay

10 lessons found to improve urban sustainability experiments

Liquid metal to 'harvest' clean hydrogen from water

Epson makes progress with sustainability plans and initiatives in Australia and New Zealand

Unlocking the benefits of avocados across the value chain

$15m AI space project to help boost Australian agriculture

Risk management approach for toxin in infant formula

The Magnum Ice Cream Company partners with Seabin for wrapper clean-up

Chemical food additive BHA under review in the US

Open Process Automation: how and where to start

OT cyber adversaries increasing real-world impact: report

Five common mistakes in industrial temperature monitoring

NSW renewables workforce receives $15m government investment

Gilmour Space opens office in South Australia